CS
Candriam SCA Portfolio holdings
AUM
$17.3B
1-Year Return
21.68%
This Quarter Return
+9.06%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$14.6B
AUM Growth
+$2.59B
(+22%)
Cap. Flow
+$828M
Cap. Flow
% of AUM
5.67%
Top 10 Holdings %
Top 10 Hldgs %
21.92%
Holding
968
New
130
Increased
364
Reduced
334
Closed
74
Top Buys
| 1 |
Microsoft
MSFT
|
+$144M |
| 2 |
Royal Bank of Canada
RY
|
+$123M |
| 3 |
Agilent Technologies
A
|
+$78.5M |
| 4 |
UnitedHealth
UNH
|
+$71.8M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$70.8M |
Top Sells
| 1 |
Bristol-Myers Squibb
BMY
|
+$92.6M |
| 2 |
Amgen
AMGN
|
+$87.9M |
| 3 |
Allstate
ALL
|
+$52.7M |
| 4 |
PayPal
PYPL
|
+$47.9M |
| 5 |
Bio-Rad Laboratories Class A
BIO
|
+$47.4M |
Sector Composition
| 1 | Healthcare | 33.43% |
| 2 | Technology | 23.21% |
| 3 | Consumer Discretionary | 9.15% |
| 4 | Financials | 8.64% |
| 5 | Communication Services | 7.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
401
Denali Therapeutics
DNLI
$2.27B
| $5M | 0.03% |
+63,781
| New | +$5M |
|
402
Robert Half
RHI
$3.66B
| $4.99M | 0.03% |
56,127
+51,425
| +1,094% | +$4.58M |
|
403
US Bancorp
USB
$75.7B
| $4.95M | 0.03% |
86,836
-9,004
| -9% | -$513K |
|
404
Kimberly-Clark
KMB
$43.1B
| $4.93M | 0.03% |
36,829
-26,313
| -42% | -$3.52M |
|
405
Restaurant Brands International
QSR
$20.3B
| $4.9M | 0.03% |
75,940
-86,009
| -53% | -$5.55M |
|
406
Mid-America Apartment Communities
MAA
$16.9B
| $4.9M | 0.03% |
29,075
+22,108
| +317% | +$3.72M |
|
407
Pfizer
PFE
$140B
| $4.89M | 0.03% |
124,825
-24,869
| -17% | -$974K |
|
408
Fiserv
FI
$73.5B
| $4.86M | 0.03% |
45,495
+11,818
| +35% | +$1.26M |
|
409
T-Mobile US
TMUS
$273B
| $4.8M | 0.03% |
33,151
+5,466
| +20% | +$792K |
|
|
KNL
410
DELISTED
Knoll, Inc.
KNL
| $4.8M | 0.03% |
+184,616
| New | +$4.8M |
|
411
Neurogene
NGNE
$278M
| $4.73M | 0.03% |
25,601
+25,599
| +1,279,950% | +$4.73M |
|
412
Bruker
BRKR
$4.67B
| $4.72M | 0.03% |
62,128
-1,071
| -2% | -$81.4K |
|
413
Ultragenyx Pharmaceutical
RARE
$3.04B
| $4.72M | 0.03% |
49,480
-48,949
| -50% | -$4.67M |
|
414
Equity Residential
EQR
$25.4B
| $4.71M | 0.03% |
32,412
-4,809
| -13% | -$698K |
|
415
ResMed
RMD
$40.9B
| $4.66M | 0.03% |
18,907
+1,132
| +6% | +$279K |
|
|
JBGS
416
JBG SMITH
JBGS
$1.42B
| $4.63M | 0.03% |
+146,796
| New | +$4.63M |
|
417
Dell
DELL
$83.2B
| $4.6M | 0.03% |
91,143
-143,086
| -61% | -$7.23M |
|
|
BHVN
418
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $4.56M | 0.03% |
47,005
-2,062
| -4% | -$200K |
|
419
Airbnb
ABNB
$76.3B
| $4.56M | 0.03% |
+29,759
| New | +$4.56M |
|
420
Etsy
ETSY
$5.77B
| $4.56M | 0.03% |
22,136
-27,016
| -55% | -$5.56M |
|
421
Clorox
CLX
$15.4B
| $4.49M | 0.03% |
19,177
-106,004
| -85% | -$24.8M |
|
422
Digital Turbine
APPS
$473M
| $4.48M | 0.03% |
58,930
+31,630
| +116% | +$2.4M |
|
423
Canadian National Railway
CNI
$59.5B
| $4.43M | 0.03% |
41,938
-34,017
| -45% | -$3.59M |
|
424
Revvity
RVTY
$10B
| $4.41M | 0.03% |
28,531
+28,514
| +167,729% | +$4.4M |
|
425
NetEase
NTES
$91.2B
| $4.4M | 0.03% |
38,150
-6,000
| -14% | -$692K |
|